77 related articles for article (PubMed ID: 26859781)
1. A potential role of the NOD genetic background in mouse peritoneal macrophages for the development of primary effusion lymphoma.
Goto H; Kariya R; Matsuda K; Kudo E; Katano H; Okada S
Leuk Res; 2016 Mar; 42():37-42. PubMed ID: 26859781
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
[TBL] [Abstract][Full Text] [Related]
3. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S
Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981
[TBL] [Abstract][Full Text] [Related]
4. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo.
Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S
Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798
[TBL] [Abstract][Full Text] [Related]
5. Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma.
Goto H; Matsuda K; Srikoon P; Kariya R; Hattori S; Taura M; Katano H; Okada S
Cancer Lett; 2013 May; 331(2):174-82. PubMed ID: 23321500
[TBL] [Abstract][Full Text] [Related]
6. Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
Goto H; Kudo E; Kariya R; Taura M; Katano H; Okada S
J Cancer Res Clin Oncol; 2015 Mar; 141(3):465-74. PubMed ID: 25304617
[TBL] [Abstract][Full Text] [Related]
7. Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma.
Goto H; Kariya R; Kudo E; Okuno Y; Ueda K; Katano H; Okada S
Oncogene; 2017 Sep; 36(37):5252-5262. PubMed ID: 28481873
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B induces apoptosis of primary effusion lymphoma via disruption of cytoskeletal organization.
Ueno M; Kariya R; Sittithumcharee G; Okada S
Phytomedicine; 2021 May; 85():153545. PubMed ID: 33799222
[TBL] [Abstract][Full Text] [Related]
9. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
[TBL] [Abstract][Full Text] [Related]
10. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
[TBL] [Abstract][Full Text] [Related]
11. Ribonucleotide reductase represents a novel therapeutic target in primary effusion lymphoma.
Dai L; Lin Z; Qiao J; Chen Y; Flemington EK; Qin Z
Oncogene; 2017 Aug; 36(35):5068-5074. PubMed ID: 28459467
[TBL] [Abstract][Full Text] [Related]
12. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts.
Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086
[TBL] [Abstract][Full Text] [Related]
13. Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma.
Gasperini P; Tosato G
Leukemia; 2009 Oct; 23(10):1867-74. PubMed ID: 19554030
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
Wu W; Rochford R; Toomey L; Harrington W; Feuer G
Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel cell line-derived xenograft model of primary herpesvirus 8-unrelated effusion large B-cell lymphoma and antitumor activity of birabresib in vitro and in vivo.
Nishimori T; Higuchi T; Hashida Y; Ujihara T; Taniguchi A; Ogasawara F; Kitamura N; Murakami I; Kojima K; Daibata M
Cancer Med; 2021 Dec; 10(24):8976-8987. PubMed ID: 34821060
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced.
O'Brien BA; Huang Y; Geng X; Dutz JP; Finegood DT
Diabetes; 2002 Aug; 51(8):2481-8. PubMed ID: 12145161
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis Deficiency of Macrophages in NOD.H-2
He X; Xiong C; Liu A; Zhao W; Xia X; Peng S; Li C; Zhou M; Li Y; Shi X; Shan Z; Teng W
Biol Trace Elem Res; 2018 Jul; 184(1):196-205. PubMed ID: 29052174
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of human hematopoietic cell engraftment into BALB/c and C57BL/6 strain of rag-2/jak3 double-deficient mice.
Ono A; Hattori S; Kariya R; Iwanaga S; Taura M; Harada H; Suzu S; Okada S
J Biomed Biotechnol; 2011; 2011():539748. PubMed ID: 21331358
[TBL] [Abstract][Full Text] [Related]
19. KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells.
Haddad L; El Hajj H; Abou-Merhi R; Kfoury Y; Mahieux R; El-Sabban M; Bazarbachi A
Leukemia; 2008 Apr; 22(4):826-34. PubMed ID: 18094712
[TBL] [Abstract][Full Text] [Related]
20. Cytologic diagnosis of primary effusion lymphoma in an HIV-negative patient.
Su YC; Chai CY; Chuang SS; Liao YL; Kang WY
Kaohsiung J Med Sci; 2008 Oct; 24(10):548-52. PubMed ID: 19181587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
